|
2023
|
Invention
|
Coordinated coexpression of thrombin.
The present invention provides methods of producing thromb... |
|
2020
|
Invention
|
Novel humanized antibodies against factor xi having anti-thrombotic and anti-inflammatory effect ... |
|
|
Invention
|
Novel humanized antibodies against factor xi having anti-thrombotic and anti-inflammatory effects... |
|
2019
|
Invention
|
Therapeutic factor xii antibody. Monoclonal antibodies that bind, such as specifically bind, bloo... |
|
|
Invention
|
Methods for safely reducing thrombopoietin.
Provided herein are methods, compounds, and composit... |
|
|
Invention
|
Methods for safely reducing thrombopoietin. Provided herein are methods, compounds, and compositi... |
|
2017
|
Invention
|
E-we thrombin analog and fibrinolytic combination.
According to the invention, a novel combinati... |
|
|
Invention
|
Antibodies against factor xi and uses thereof. The present invention in general relates to novel ... |
|
|
Invention
|
Novel antibodies against factor xi and uses thereof. The present invention in general relates to ... |
|
2014
|
Invention
|
Coordinated coexpression of thrombin. The present invention provides methods of producing thrombi... |
|
2013
|
Invention
|
Antibodies against factor xii and uses thereof. Provided are antibodies that selectively bind to ... |
